Intrauterine Contraceptive Device Insertion During Cesarean Section (CS) Versus Delayed Insertion
Patient's Compliance to Intrauterine Device: Immediate Postplacental Insertion Versus Delayed Insertion in Women Undergoing Planned Cesarean Section
1 other identifier
interventional
80
1 country
1
Brief Summary
After ethical committee approval and written consent from the patients, this prospective quasi-randomized controlled clinical trial was performed on pregnant women planning to deliver by cesarean section and willing to participate in the study to investigate the value of immediate post placental IUD insertion versus delayed insertion on patient's compliance in Ain Shams University Maternity Hospital (ASUMH).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedFirst Submitted
Initial submission to the registry
May 14, 2022
CompletedFirst Posted
Study publicly available on registry
May 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2022
CompletedJune 23, 2022
June 1, 2022
1 year
May 14, 2022
June 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient compliance
compliance to IUD will be assessed by a user satisfaction questionnaire with scoring system: Q1, on a scale from 0 to 10, Are You satisfied of using Cu-IUD as a contraceptive method? (When 0 means "Not at all satisfied" and 10 means "Extremely Satisfied") 0 1 2 3 4 5 6 7 8 9 10 Q2, Will you continue to use Cu-IUD in future or reuse it after discontinuation? 1 = Yes 0 = No Q3, Do you recommend Cu-IUD for others to use it as a contraceptive method? 1 = Yes 0 = No
at 6 months after the procedure
Patient compliance
compliance to IUD will be assessed by a user satisfaction questionnaire with scoring system: Q1, on a scale from 0 to 10, Are You satisfied of using Cu-IUD as a contraceptive method? (When 0 means "Not at all satisfied" and 10 means "Extremely Satisfied") 0 1 2 3 4 5 6 7 8 9 10 Q2, Will you continue to use Cu-IUD in future or reuse it after discontinuation? 1 = Yes 0 = No Q3, Do you recommend Cu-IUD for others to use it as a contraceptive method? 1 = Yes 0 = No
at 12 months after the procedure
Secondary Outcomes (5)
Abnormal Bleeding pattern
at 12 months after the procedure
dyspareunia
at 12months after the procedure
Efficiency
at 6 months after the procedure
Efficiency
at 12 months after the procedure
Anemia
at 12months after the procedure
Study Arms (2)
postplacental IUD (PP-IUD) insertion
ACTIVE COMPARATORpatients will have immediate postplacental IUD insertion
delayed IUD insertion
ACTIVE COMPARATORcesarean section will be done, then contacts will be taken to arrange for delayed IUD insertion at the 6th week postpartum visit
Interventions
patients will have immediate postplacental IUD insertion as follows: The IUD is inserted after removal of the placenta and after the uterus has become hemostatic. After initiating closure of the uterine incision, the IUD is placed at the top of uterine fundus manually. Before closing the uterine incision, the strings are placed gently in the lower uterine segment manually. After this is accomplished, the uterine incision closure can be completed. The strings will usually descend spontaneously through the cervix during the puerperal period. If the cervix is closed, it'll be dilated from above with ring forceps. Strings can be passed through the cervix with ring forceps. If this is done, the surgeon will recheck to make sure IUD remains at the fundus of the uterus prior to closing the uterine incision. Strings can be trimmed at a follow-up visit. Ultrasound will be done after the CS to ensure proper placement of the IUD.
cesarean section will be done, then contacts will be taken to arrange for delayed IUD insertion at the 6th week postpartum visit as follows: Prepare IUD prior to starting procedure Place vaginal speculum then prepare vaginal wall with betadine Apply tenaculum at anterior cervical position then insert and remove uterine sound Place IUD according to package insert then cut threads 2-3 cm from cervical os. Ultrasound will be done to ensure proper placement of the IUD.
Eligibility Criteria
You may qualify if:
- Pregnant women planned for delivery by cesarean section in Ain Shams University Maternity hospital
You may not qualify if:
- Women not consenting to use IUD as a contraceptive method and preferring other methods.
- Any woman with condition included in Category 3 or 4 for Cu-IUD in medical eligibility criteria for contraceptive use World Health Organization (WHO) 2015
- Neuropsychiatric disorder causing altered mentality or perception
- Intrapartum complications as chorioamnionitis, massive blood loss, or hysterectomy.
- Anemic patients (hemoglobin level \<10g/dl).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams Maternity Hospital
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mohamed Sweed, MD
Faculty of Medicine Ain Shams University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- masking is not applicable
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
May 14, 2022
First Posted
May 20, 2022
Study Start
May 1, 2021
Primary Completion
May 1, 2022
Study Completion
June 5, 2022
Last Updated
June 23, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ANALYTIC CODE
- Time Frame
- individual participant data with supporting information will be available after study completion for 6 months after publication
- Access Criteria
- reasonable requests aiming for extending the benefit to more patients, or asking about the procedures done, will be assessed by the principal investigator and/or the study official, and shared either by contact e-mails or data repository when available
upon reasonable request to the principal investigator, individual participant data can be shared